These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1304829)

  • 21. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of thermoresistance spores of Clostridium difficile strains belonging to different toxigenicity groups].
    Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2004; 56(2):155-9. PubMed ID: 15544087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal enterocolitis in Asian elephants (Elephas maximus) caused by Clostridium difficile.
    Bojesen AM; Olsen KE; Bertelsen MF
    Vet Microbiol; 2006 Sep; 116(4):329-35. PubMed ID: 16737787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.
    Willey SH; Bartlett JG
    J Clin Microbiol; 1979 Dec; 10(6):880-4. PubMed ID: 521486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAXONOMY OF CLOSTRIDIUM BIFERMENTANS AND CLOSTRIDIUM SORDELLII. I. THEIR TOXIGENICITY, UREASE ACTIVITY, AND SPORULATING POTENCY.
    NISIDA S; TAMAI K; YAMAGISHI T
    J Bacteriol; 1964 Dec; 88(6):1641-6. PubMed ID: 14240951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of novel assays to assess the influence of different iron sources on the growth of Clostridium difficile.
    Cernat RC; Scott KP
    Anaerobe; 2012 Jun; 18(3):298-304. PubMed ID: 22554901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAXONOMY OF CLOSTRIDIUM BIFERMENTANS AND CLOSTRIDIUM SORDELLII. II. TOXIGENIC AND SPORULATING POTENCIES IN SUBSTRAINS OF A CLOSTRIDIUM SORDELLII STRAIN.
    TAMAI K; NISHIDA S
    J Bacteriol; 1964 Dec; 88(6):1647-51. PubMed ID: 14240952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of diagnostic antitoxic serum to Clostridium difficile].
    Alchinbaeva VM; Bakulin IN; Mironova LL; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):22-4. PubMed ID: 2735166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis.
    Welch DF; Menge SK; Matsen JM
    J Clin Microbiol; 1980 May; 11(5):470-3. PubMed ID: 7381011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the role of p-cresol tolerance in Clostridium difficile.
    Dawson LF; Stabler RA; Wren BW
    J Med Microbiol; 2008 Jun; 57(Pt 6):745-749. PubMed ID: 18480332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for working with the mouse model.
    Collignon A
    Methods Mol Biol; 2010; 646():229-37. PubMed ID: 20597013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlative properties for a differentiation of two Clostridium sordellii phenotypes and their distinction from Clostridium bifermentans.
    Roggentin P; Gutschker-Gdaniec G; Schauer R; Hobrecht R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Nov; 260(3):319-28. PubMed ID: 3911662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.
    Dailey DC; Kaiser A; Schloemer RH
    Infect Immun; 1987 Jul; 55(7):1541-6. PubMed ID: 3596798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAXONOMY OF CLOSTRIDIUM BIFERMENTANS AND CLOSTRIDIUM SORDELLII. 3. AGGLUTINABILITY OF HEAT-RESISTANT SUBSTRAINS OFCLOSTRIDIUM SORDELLII.
    HUANG CT; TAMAI K; NISHIDA S
    J Bacteriol; 1965 Aug; 90(2):391-4. PubMed ID: 14330732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies.
    Libby JM; Wilkins TD
    Infect Immun; 1982 Jan; 35(1):374-6. PubMed ID: 6172384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to methodologic variables that impact growth of Clostridium difficile in a broth culture medium without requirement for anaerobic culture conditions.
    Connor MC; McGrath JW; McMullan G; Marks N; Fairley DJ
    Anaerobe; 2019 Apr; 56():135. PubMed ID: 30615945
    [No Abstract]   [Full Text] [Related]  

  • 37. Methodologic variables that impact growth of Clostridium difficile in a broth culture medium without requirement for anaerobic culture conditions.
    Cadnum JL; Donskey CJ
    Anaerobe; 2019 Apr; 56():133-134. PubMed ID: 30682434
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of
    Ohashi Y; Fujisawa T
    Biosci Microbiota Food Health; 2019; 38(2):65-68. PubMed ID: 31106109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Purification and concentration of antitoxic sera].
    Sezginman N; Demirtaş N
    Turk Hij Tecr Biyol Derg (1961); 1970; 30(1):63-75. PubMed ID: 5469942
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research on C1 deaminases. bifermentans and C1. sordellii].
    PREVOT AR; COHEN GN; NISMAN B
    Ann Inst Pasteur (Paris); 1947 Aug; 73(8):834-6. PubMed ID: 18901418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.